Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Hold
91,933
0.96% 25
2026
Q1
$11.1M Sell
91,933
-4,076
-4% -$471K 1.06% 19
2025
Q4
$10.2M Sell
96,009
-2,627
-3% -$247K 0.86% 22
2025
Q3
$8.36M Sell
98,636
-441
-0.4% -$36.3K 0.71% 27
2025
Q2
$7.92M Sell
99,077
-149
-0.2% -$11.8K 0.72% 29
2025
Q1
$8.99M Sell
99,226
-334
-0.3% -$31.2K 0.91% 23
2024
Q4
$9.99M Sell
99,560
-4,638
-4% -$478K 0.94% 21
2024
Q3
$11.9M Sell
104,198
-1,365
-1% -$162K 1.09% 13
2024
Q2
$13.1M Buy
105,563
+14,921
+16% +$1.92M 1.26% 9
2024
Q1
$12M Sell
90,642
-283
-0.3% -$34.9K 1.2% 14
2023
Q4
$9.98M Sell
90,925
-579
-0.6% -$60.1K 1.11% 14
2023
Q3
$9.49M Sell
91,504
-54
-0.1% -$5.82K 1.17% 13
2023
Q2
$10.6M Hold
91,558
1.26% 11
2023
Q1
$9.81M Sell
91,558
-4,919
-5% -$531K 1.27% 11
2022
Q4
$10.8M Sell
96,477
-11,352
-11% -$1.16M 1.42% 7
2022
Q3
$9.36M Hold
107,829
1.3% 10
2022
Q2
$9.9M Buy
107,829
+2,283
+2% +$202K 1.29% 11
2022
Q1
$8.73M Buy
105,546
+2,360
+2% +$186K 0.96% 18
2021
Q4
$7.98M Hold
103,186
0.83% 23
2021
Q3
$7.82M Hold
103,186
0.92% 22
2021
Q2
$8.09M Sell
103,186
-4,953
-5% -$368K 0.96% 21
2021
Q1
$8.09M Hold
108,139
1.04% 18
2020
Q4
$8.51M Hold
108,139
1.15% 16
2020
Q3
$8.62M Sell
108,139
-3,480
-3% -$273K 1.31% 13
2020
Q2
$8.3M Hold
111,619
1.34% 11
2020
Q1
$8.26M Buy
111,619
+12,489
+13% +$982K 1.61% 10
2019
Q4
$8.66M Hold
99,130
1.57% 10
2019
Q3
$8.02M Hold
99,130
1.6% 10
2019
Q2
$7.98M Hold
99,130
1.62% 10
2019
Q1
$7.87M Sell
99,130
-3,997
-4% -$299K 1.66% 11
2018
Q4
$7.57M Buy
+103,127
New +$7.28M 2.24% 8

Other funds holding MRK

Kintegral Advisory's MRK Position: Q2 2026 in Review

Kintegral Advisory held its Merck (MRK) position steady in Q2 2026 at 91,933 shares worth $11.9M. The position accounts for 0.96% of the portfolio, ranked #25.

Kintegral Advisory first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $13.1M in Q2 2024. 1,598 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kintegral Advisory held 91,933 shares of Merck worth $11.9M as of Q2 2026.
  • Kintegral Advisory left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.96% of Kintegral Advisory's portfolio in Q2 2026, its #25 holding.
  • Kintegral Advisory first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
  • Kintegral Advisory's Merck position peaked at $13.1M in Q2 2024.
  • 1,598 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.